Quang-De Nguyen

Title: Quang-De Nguyen: Innovator in Molecular Imaging

Introduction

Quang-De Nguyen is a prominent inventor based in London, GB. He has made significant contributions to the field of molecular imaging, particularly in the development of innovative polypeptides for cancer monitoring and treatment.

Latest Patents

Nguyen holds two patents that showcase his expertise. The first patent involves HER2 polypeptides useful for imaging and monitoring tumors and cancers. This method describes the use of an isolated polypeptide conjugated with a radionuclide, specifically designed to bind to HER2 or its variants. This innovation is aimed at monitoring the response to HSP90 inhibition and utilizes the isolated polypeptide conjugated with 18F as an imaging agent. The second patent focuses on isatin derivatives for use as in vivo imaging agents. It details isatin 5-sulfonamide derivatives and their pharmaceutical compositions, which serve as molecular imaging agents for diagnosing or treating diseases related to apoptosis dysregulation.

Career Highlights

Throughout his career, Quang-De Nguyen has worked with notable companies such as Imperial Innovations Limited and GE Healthcare Limited. His work in these organizations has allowed him to advance his research and contribute to significant developments in the medical field.

Collaborations

Nguyen has collaborated with esteemed colleagues, including Eric Ofori Aboagye and Duncan Robert R Hiscock. These partnerships have further enriched his research and innovation efforts.

Conclusion

Quang-De Nguyen is a distinguished inventor whose work in molecular imaging has the potential to transform cancer diagnosis and treatment. His patents reflect a commitment to advancing medical technology and improving patient outcomes.